Fig. 1From: In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity mattersVaccination protocol. Mice were either given repetitive prophylactic or therapeutic injections of two different cell line-derived whole tumor lysates. In the case of therapeutic application, mice were additionally given 3 monthly injections of gemcitabine. The scheme was created with BioRender.comBack to article page